Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Neck Cancer: early-phase trial registry

2 of 5 indexed Neck Cancer trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Neck Cancer: 5 US clinical trials tracked, 2 recruiting.

Neck Cancer is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Davis, running 1 of these trials.

Enrollment posture brief

Registry condition neck-cancer

OPEN 2 | RECR 40% | LATE 0 | EARLY 3 | RANK #3391 | SPON 1

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Neck Cancer (this)40%
Open-enrollment share among volume-matched conditions near Neck Cancer

Neck Cancer lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Neck Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Neck Cancer is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Neck Cancer research.

    University of California, Davis accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Neck Cancer trials plan to enrol fewer than 100 people.

    Median target enrolment is 55 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Neck Cancer research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13

Phase Distribution

PhaseTrial count
Phase 1 3

Named interventions

Most-linked intervention names on Neck Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

3T MRI scan Procedure
1 trials
Lay Navigation Other
1 trials
Bintrafusp Alfa Drug
1 trials
PDS01ADC Drug
1 trials
exercise and nutritional prehabilitation Behavioral
1 trials
Entinostat Drug
1 trials
Cetuximab Drug
1 trials
Cisplatin Drug
1 trials

US sites by state

Facility locations filed on Neck Cancer trials. A trial with sites in several states counts in each.

California 2 trials
New York 1 trials
New Jersey 1 trials
Michigan 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Neck Cancer page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neck Cancer condition card totals 5 registered trials; most-linked intervention 3T MRI scan; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.